Trump is looking for drugmakers to come through for him. They have a wish list for him, too

Taking stock of the drug industry, from the lab to the medicine chest

February 27, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Alex Brandon/AP STAT+ | Trump is looking for drugmakers to come through for him. They have a wish list for him, too Eli Lilly's recent manufacturing announcement was a reminder Trump is looking for drugmakers to come through for him. They have a wish list for him, too. By Ed Silverman STAT+ | New kids on the block: A new generation of VCs ventures into biotech STAT Who to Know series looks at up-and-coming venture capital firms including Dimension Capital, KdT Ventures, Atria Ventures, Age1, Yosemite, and more. By Allison DeAngelis STAT+ | FDA cancels vaccine advisory committee meeting The meeting is a critical resource for vaccine makers trying to figure out which flu strains to include in their shots for the next flu season. By Lizzy Lawrence Adobe STAT+ | How to eliminate biotech zombies: Buy them Health care investor Kevin Tang has an ingenious solution to the sector's intractable problem, covered in last week's edition of "Adam's Biotech Scorecard." By Adam Feuerstein

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser